Quarterly report · Q2
6951.TEDINET S100O9I5
Period2021-04-01 → 2021-09-30
Filed2022-06-16
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100MQ4F.
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥110.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥49.4bn | 2020-04-01 → 2020-09-30 | Cons. | Net sales |
| Operating income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Operating income | ¥2.5bn | 2020-04-01 → 2020-09-30 | Cons. | Operating income |
| Ordinary income | ¥4.7bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.5bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2020-04-01 → 2020-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.8bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.9bn | 2020-04-01 → 2020-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2020-04-01 → 2020-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2020-04-01 → 2020-09-30 | Cons. | Profit loss |
| Total assets | ¥168.3bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥146.4bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥136.7bn | at 2020-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥90.9bn | at 2021-09-30 | Cons. | Liabilities |
| Total liabilities | ¥95.4bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥77.4bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥51.0bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥46.9bn | at 2020-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥31.9bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥30.2bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.5bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2020-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥662m | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥438m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥11.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥75.56 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.59 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.51 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40 | 2020-04-01 → 2020-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.6 | 2020-07-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.3% | at 2020-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥2.3bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥5.8bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥820m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥670m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2020-09-30 | −¥2.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥12.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥12.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥737m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥30.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥30.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2020-04-01 → 2020-09-30 | −¥288m |
| —segment total | revenue | 2020-04-01 → 2020-09-30 | ¥49.4bn |
| —segment total | revenue external | 2020-04-01 → 2020-09-30 | ¥49.4bn |
| —segment total | segment profit | 2020-04-01 → 2020-09-30 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes payable | Prior1YearInstant | 1072000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 1392000000 | JPY |
| Advances received | Prior1YearInstant | 13890000000 | JPY |
| Advances received | CurrentQuarterInstant | 19009000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1463000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 1442000000 | JPY |
| Other cl | Prior1YearInstant | 14248000000 | JPY |
| Other cl | CurrentQuarterInstant | 14229000000 | JPY |
| Current liabilities | Prior1YearInstant | 67212000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 65927000000 | JPY |
| Bonds payable | Prior1YearInstant | 390000000 | JPY |
| Bonds payable | CurrentQuarterInstant | 297000000 | JPY |
| Long term loans payable | Prior1YearInstant | 16867000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 13678000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 15000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 18000000 | JPY |
| Provision for management board incentive plan trust | Prior1YearInstant | 338000000 | JPY |
| Provision for management board incentive plan trust | CurrentQuarterInstant | 362000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 8250000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 8394000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 321000000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 316000000 | JPY |
| Other ncl | Prior1YearInstant | 1993000000 | JPY |
| Other ncl | CurrentQuarterInstant | 1951000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 28176000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 25019000000 | JPY |
| Liabilities | Prior1YearInstant | 95388000000 | JPY |
| Liabilities | CurrentQuarterInstant | 90947000000 | JPY |
| Capital stock | Prior1YearInstant | 10037000000 | JPY |
| Capital stock | CurrentQuarterInstant | 21394000000 | JPY |
| Capital surplus | Prior1YearInstant | 9914000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 21271000000 | JPY |
| Retained earnings | Prior1YearInstant | 29664000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 32788000000 | JPY |
| Treasury stock | Prior1YearInstant | -1059000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1022000000 | JPY |
| Shareholders equity | Prior1YearInstant | 48558000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 74431000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 4113000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 4400000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -25000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -22000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -1458000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | -1247000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -188000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -160000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 2441000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 2969000000 | JPY |
| Net assets | Prior1YearInstant | 50999000000 | JPY |
| Net assets | CurrentQuarterInstant | 77400000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |